Where is AbTherx located?

AbTherx is headquartered in Mountain View, United States.

How many employees does AbTherx have?

As of May 31, 2026, the latest employee count at AbTherx is 13.

Is AbTherx a funded company?

AbTherx is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does AbTherx rank among its competitors?

AbTherx ranks 48th amongst 815 active competitors, of which 55 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Alloy Therapeutics, which secured $40M in Mar, 2026.

Who are the top competitors of AbTherx?

AbTherx's top competitors include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Among them, Alloy Therapeutics secured the most recent funding round in March, 2026.

AbTherx - 2026 Company Profile & Competitors

AbTherx is an unfunded company based in Mountain View (United States), founded in 2023. It operates as a CRO focused on antibody development services. AbTherx has not raised any funding yet. The company has 815 active competitors, including 55 funded and 49 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.

Key Metrics

Founded Year

2023

Location

Mountain View, United States

Stage

Unfunded

Ranked

48^th among 815 active competitors

Employee Count

13 as on May 31, 2026

Similar Companies

Alloy Therapeutics & 836 more

View AbTherx's full profile

AbTherx has not raised any funding rounds yet.

AbTherx's employee count trend

AbTherx has 13 employees as of May 26. Here is AbTherx's employee count trend over the years:

Uncover AbTherx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AbTherx include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of AbTherx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	63/100
2nd	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano-Vista & 25 others	61/100
3rd	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, HHS & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	58/100
5th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	53/100
6th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Shunwei Capital, Panacea Venture & 17 others	53/100
7th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Bpifrance & 4 others	52/100
8th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	AlleyCorp, KdT Ventures	51/100
9th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Spinnotec, ShenZhen GTJA Investment Group ... & 3 others	51/100
10th	Qyuns Therapeutics 2015, Taizhou (China), Public	Provider of drug development services to biopharma sector	$66.3M	Matrix Partners China, Shenzhen Ruixiangyuan Fund Management ... & 5 others	50/100
48th	AbTherx 2023, Mountain View (United States), Unfunded	CRO focused on antibody development services	-	-	37/100